PMC:7283670 / 83195-83981
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T273 | 77-90 | Body_part | denotes | interleukin‐6 | http://purl.org/sig/ont/fma/fma264829 |
| T274 | 77-88 | Body_part | denotes | interleukin | http://purl.org/sig/ont/fma/fma86578 |
| T275 | 98-108 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
| T276 | 127-134 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T277 | 354-359 | Body_part | denotes | organ | http://purl.org/sig/ont/fma/fma67498 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T176 | 354-359 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T689 | 77-90 | http://purl.obolibrary.org/obo/PR_000001393 | denotes | interleukin‐6 |
| T690 | 354-359 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T328 | 127-134 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T329 | 196-202 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
| T330 | 231-237 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T725 | 25-49 | Sentence | denotes | One‐month mortality rate |
| T726 | 50-76 | Sentence | denotes | Secondary (up to 1 month): |
| T727 | 77-699 | Sentence | denotes | interleukin‐6 level, lymphocyte count, C‐reactive protein level (cycle 1 and 2 every 12 hr), PaO2 (partial pressure of oxygen)/FiO2 (fraction of inspired oxygen, FiO2) ratio (or P/F ratio) (baseline, during treatment (cycle 1 and 2 every 12 hr), change of the SOFA (sequential organ failure assessment) (baseline, during treatment (cycle 1 and 2 every 12 hr), number of participants with treatment‐related side effects as assessed by Common Terminology Criteria for Adverse Event version 5.0, Radiological response, Time Frame: at baseline (optional), after 7 days and if clinically indicated, duration of hospitalization. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1857 | 77-90 | Gene | denotes | interleukin‐6 | Gene:3569 |
| 1858 | 116-134 | Gene | denotes | C‐reactive protein | Gene:1401 |
| 1948 | 447-459 | Species | denotes | participants | Tax:9606 |
| 1949 | 732-739 | Species | denotes | patient | Tax:9606 |